Antimicrobial claims for antigingivitis/plaque agents not supported -- subcommittee.

ANTIGINGIVITIS AGENTS "ANTIMICROBIAL" STATEMENT OF IDENTITY is "not consistent" with the deliberations of FDA's Dental Plaque Subcommittee, Sheila McGuire-Riggs, DDS, Wellmark, Blue Cross/Blue Shield of Iowa, declared at its May 28 meeting in Gaithersburg, Md. The advisory group met to continue the development of FDA's OTC antigingivitis drug products monograph and to discuss specific labeling and final formulation testing requirements for products included in the rulemaking.